Latest Content

If a car had a 50% chance of crashing, I would never let my son in it. With a hereditary cancer syndrome, though, there's no safety feature to lessen the odds. The mutation is simply there, or it isn't.

Dr. Gregory Tiesi discusses TAMP, a targeted therapy that delivers chemotherapy directly to pancreatic tumors with fewer side effects.

A kidney cancer survivor shares how a decade of breakthroughs in immunotherapy and targeted research transformed a death sentence into a life saved.

CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating development for patients with few options.

New research shows adults over 80 with early-stage lung cancer can achieve surgical outcomes and quality of life comparable to younger patients.

Cogent submitted an FDA application for bezuclastinib after the phase 3 PEAK trial shows improved progression-free survival in patients with previously treated GIST.

Although I know better, I gardened in a sleeveless shirt and ended up with a poison ivy rash on my lymphedema limb. This time, I was lucky. Hopefully I will follow my own advice and avoid tempting fate next time.

Nurse Bridget Hopkins shares how she navigates metastatic breast cancer through second opinions, "YOLO" trips and the power of advanced care planning.

The phase 3 EMERALD-3 trial shows Imfinzi and Imjudo plus Lenvima and embolization improved progression-free survival in unresectable liver cancer.

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care without invasive surgery.

A study found blood-based genomic testing can be completed in 27 hours, giving patients with cancer faster treatment decisions.

Eleven years with Stage 4 breast cancer, all on the first line of treatment. It isn’t chronic, but what is it?

Multiple myeloma survivor JP Kealy and wife Annamarie share how to avoid cancer burnout and why this journey is a marathon, not a sprint.